Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
News: Latest News
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
All NewsEconomyCurrencies & ForexCryptocurrenciesCybersecurityPress Releases

Pharmacies ordered to pay $650.6 million to Ohio counties in opioid case

08/17/2022 | 12:44pm EDT
FILE PHOTO: Tablets of the opioid-based Hydrocodone at a pharmacy in Portsmouth

(Reuters) -Pharmacy operators CVS, Walmart and Walgreens must pay a combined $650.6 million to two Ohio counties to address the damage done by the opioid epidemic, a federal judge ruled on Wednesday.

The order by U.S. Judge Dan Polster in Cleveland comes after a jury last November concluded that the pharmacy chains helped create a public nuisance in Lake and Trumbull counties by over-supplying addictive pain pills, many of which found their way onto the black market. The pharmacies have said they would appeal that verdict.

Polster held a separate non-jury trial earlier this year to decide how much the companies had to pay.

"We are disappointed with this outcome," Walgreens spokesman Fraser Engleman said in a statement. "The facts and the law did not support the jury verdict last fall, and they do not support the court's decision now."

CVS and Walmart did not immediately respond to requests for comment.

Polster said the sum must be paid over 15 years, with the amount for the first two years, or $86.7 million, to be paid into a fund immediately. The judge also ordered the companies to implement new procedures to combat illegal diversion of opioid drugs.

The U.S. opioid epidemic has caused more than 500,000 overdose deaths over two decades, according to government data. More than 3,300 opioid lawsuits have been filed nationally against drugmakers, distributors and pharmacy chains.

The litigation has resulted in several nationwide settlements, including a $26 billion deal with Johnson & Johnson and the three leading distributors, a $2.37 billion settlement with AbbVie Inc and a $4.25 billion settlement with Teva Pharmaceutical Industries Ltd.

Pharmacies have yet to reach a nationwide settlement.

(Reporting By Brendan Pierson in New York; Editing by David Evans, Alexia Garamfalvi and Emelia Sithole-Matarise)

By Brendan Pierson and Dietrich Knauth


© Reuters 2022
Stocks mentioned in the article
ChangeLast1st jan.
ABBVIE INC. 3.06% 138.32 Delayed Quote.-0.88%
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 1.98% 8.23 Delayed Quote.2.75%
WALMART INC. 2.18% 132.53 Delayed Quote.-10.36%
Latest news "Economy & Forex"
05:36pThe WSJ Dollar Index Falls 0.62% to 103.31 -- Data Talk
DJ
05:36pEuro Gains 0.23% to $0.9825 -- Data Talk
DJ
05:36pSterling Gains 1.38% to $1.1322 -- Data Talk
DJ
05:36pDollar Lost 0.11% to 144.56 Yen -- Data Talk
DJ
05:35pExclusive-Elliott Management's utilities lead Rosenbaum leaves firm -sources
RE
05:33pRocket builder Firefly nails crucial milestone with first mission success
RE
05:31pDogecoin Gained 0.50% to $0.060 at 5 p.m. ET -- Data Talk
DJ
05:31pEthereum Gained 1.55% to $1323.92 at 5 p.m. ET -- Data Talk
DJ
05:31pBitcoin Gained 1.86% to $19589.94 at 5 p.m. ET -- Data Talk
DJ
05:29pWheat futures retreat after nearing three-month high at CBOT
RE
Latest news "Economy & Forex"